Collegium Pharmaceutical

COLLNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$741.617 M

$22.78 -1.13%

Close of 22 Sept 2026

Revenue

$780.6M

#1667 by revenue

Earnings

$63.0M

#1483 by earnings

Shares outstanding

32,555,613

Latest filing cover page

P/E ratio

11.8

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#182Nuvectis PharmaNVCT$750.1M
#183Ironwood PharmaceuticalsIRWD$747.7M
#184Collegium PharmaceuticalCOLL$741.6M
#185MapLight TherapeuticsMPLT$703.4M
#186Zevra TherapeuticsZVRA$687.7M

What if Collegium Pharmaceutical were worth as much as…

Open the what-if tool →

Gold $30.2T

$928,686.85

Per share 40,768× higher

Bitcoin $1.74T

$53,497.84

Per share 2,348× higher

Nvidia $5.52T

$169,425.99

Per share 7,437× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Collegium Pharmaceutical are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.